These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2943136

  • 1. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H, Wedel I.
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
    [Abstract] [Full Text] [Related]

  • 2. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S, Nahorski SR.
    Eur J Pharmacol; 1982 Jul 09; 81(2):273-85. PubMed ID: 7117377
    [Abstract] [Full Text] [Related]

  • 3. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M, Hidaka K, Nakamura Y.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):177-82. PubMed ID: 2576228
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
    Malmberg A, Jerning E, Mohell N.
    Eur J Pharmacol; 1996 May 06; 303(1-2):123-8. PubMed ID: 8804920
    [Abstract] [Full Text] [Related]

  • 7. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
    Grigoriadis D, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 06; 332(1):21-5. PubMed ID: 2869417
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ, Seeman P.
    Proc Natl Acad Sci U S A; 1981 Apr 06; 78(4):2620-4. PubMed ID: 6941314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 06; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun 06; 329(4):333-43. PubMed ID: 2863760
    [Abstract] [Full Text] [Related]

  • 15. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P, Tallerico T, Ko F.
    Synapse; 2003 Sep 15; 49(4):209-15. PubMed ID: 12827639
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ, Iversen LL.
    J Neurochem; 1981 Nov 15; 37(5):1130-43. PubMed ID: 7299392
    [Abstract] [Full Text] [Related]

  • 17. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG, Sinha YN, Finch CE.
    Neuroendocrinology; 1984 May 15; 38(5):407-10. PubMed ID: 6728123
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.